These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10765035)

  • 1. Susceptibility of clinical strains of herpes simplex virus to three nucleoside analogues.
    Edert DY; Finance CM; Le Faou AE
    Chemotherapy; 2000; 46(3):195-7. PubMed ID: 10765035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Profiling penciclovir susceptibility and prevalence of resistance of herpes simplex virus isolates across eleven clinical trials.
    Sarisky RT; Bacon TH; Boon RJ; Duffy KE; Esser KM; Leary J; Locke LA; Nguyen TT; Quail MR; Saltzman R
    Arch Virol; 2003 Sep; 148(9):1757-69. PubMed ID: 14505088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral therapy of herpes simplex and varicella-zoster virus infections.
    Wutzler P
    Intervirology; 1997; 40(5-6):343-56. PubMed ID: 9675639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aciclovir resistance among Indian strains of Herpes simplex virus as determined using a dye uptake assay.
    Abraham AM; Kavitha S; Joseph P; George R; Pillay D; Malathi J; Jesudason MV; Sridharan G
    Indian J Med Microbiol; 2007 Jul; 25(3):260-2. PubMed ID: 17901647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical utility of susceptibility testing of herpes simplex virus to acyclovir].
    Otegui M; Rabella N; Labeaga R; Herrero M; Margall N; Muñoz JM; Prats G
    Rev Esp Quimioter; 2001 Dec; 14(4):351-7. PubMed ID: 11856981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
    Safrin S; Phan L
    Antimicrob Agents Chemother; 1993 Oct; 37(10):2241-3. PubMed ID: 8257152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral susceptibility of Herpes simplex viruses and its clinical correlates: a single center's experience.
    Rabella N; Otegui M; Labeaga R; Rodríguez P; Margall N; Gurguí M; Prats G
    Clin Infect Dis; 2002 Apr; 34(8):1055-60. PubMed ID: 11914993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients.
    Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L
    Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug susceptibilities of isolates of varicella-zoster virus in a clinical study of oral brovavir.
    Machida H; Nishitani M
    Microbiol Immunol; 1990; 34(4):407-11. PubMed ID: 2163486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antiviral efficacies of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (brovavir) and acyclovir against herpes simplex virus type 1 infections in mice.
    Machida H; Ikeda T; Ashida N
    Antiviral Res; 1990 Aug; 14(2):99-107. PubMed ID: 2177319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Andrei G; De Clercq E; Snoeck R
    Antiviral Res; 2004 Mar; 61(3):181-7. PubMed ID: 15168799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus resistant to acyclovir: A single-centre experience from the Czech Republic.
    Fajfr M; Pliskova L; Bolehovská R; Uhlířová Z; Vrbacký F
    J Glob Antimicrob Resist; 2019 Dec; 19():269-273. PubMed ID: 31100505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Coen DM; Fleming HE; Leslie LK; Retondo MJ
    J Virol; 1985 Feb; 53(2):477-88. PubMed ID: 2982032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Resistance of herpes simplex virus to acyclovir: laboratory and clinical aspects].
    Briazzhikova TS; Iurlova TI; Chizhov NP
    Antibiot Khimioter; 1995; 40(11-12):29-33. PubMed ID: 8830636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for acyclovir-resistant herpes simplex virus isolates from clinical samples.
    Mah IW; Kuo BI; Wei HY; Tsai CH; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1997 Feb; 30(1):51-4. PubMed ID: 10592810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Isolation of acyclovir-resistant strains of herpes simplex virus from clinical material].
    L'vov ND; Andronova VL; Leont'eva NA; Galegov GA
    Vopr Virusol; 1999; 44(6):247-9. PubMed ID: 10665057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative study of resistance to acycloguanosine and acycloguanosine H-phosphonate in herpes simplex virus].
    Andronova VL; Galegov GA; Ias'ko MV; Kukhanova MK; Skoblov IuS
    Vopr Virusol; 2010; 55(1):31-4. PubMed ID: 20364669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of varicella-zoster virus to thymidine analogues.
    Machida H
    Biken J; 1986 Mar; 29(1):1-6. PubMed ID: 3022708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aciclovir on the replication of herpes simplex virus type 1 in MA-104 cell line resistant to aciclovir.
    Cinatl J; Cinatl J; Rabenau H; Mainke M; Kornhuber B; Doerr HW
    Arzneimittelforschung; 1992 Jul; 42(7):977-80. PubMed ID: 1329781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    Schmit I; Boivin G
    J Infect Dis; 1999 Aug; 180(2):487-90. PubMed ID: 10395866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.